Castle Total Current Assets vs Net Debt Analysis

CSTL Stock  USD 27.48  0.05  0.18%   
Castle Biosciences financial indicator trend analysis is way more than just evaluating Castle Biosciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Castle Biosciences is a good investment. Please check the relationship between Castle Biosciences Total Current Assets and its Net Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Castle Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.

Total Current Assets vs Net Debt

Total Current Assets vs Net Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Castle Biosciences Total Current Assets account and Net Debt. At this time, the significance of the direction appears to have pay attention.
The correlation between Castle Biosciences' Total Current Assets and Net Debt is -0.91. Overlapping area represents the amount of variation of Total Current Assets that can explain the historical movement of Net Debt in the same time period over historical financial statements of Castle Biosciences, assuming nothing else is changed. The correlation between historical values of Castle Biosciences' Total Current Assets and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Assets of Castle Biosciences are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Total Current Assets i.e., Castle Biosciences' Total Current Assets and Net Debt go up and down completely randomly.

Correlation Coefficient

-0.91
Relationship DirectionNegative 
Relationship StrengthSignificant

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.
Most indicators from Castle Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Castle Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Castle Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.Tax Provision is expected to rise to about 125 K this year, although the value of Selling General Administrative will most likely fall to about 50.2 M.
 2021 2022 2023 2024 (projected)
Interest Expense1K17K11K10.5K
Depreciation And Amortization3.4M10.5M12.3M12.9M

Castle Biosciences fundamental ratios Correlations

-0.770.830.911.00.410.980.780.81-0.82-0.720.640.830.8-0.360.710.420.970.820.950.960.42-0.480.910.720.97
-0.77-0.52-0.53-0.79-0.56-0.78-0.5-0.340.80.41-0.34-0.8-0.530.17-0.640.02-0.81-0.35-0.64-0.750.020.5-0.54-0.4-0.85
0.83-0.520.910.820.120.760.990.78-0.43-0.980.940.50.97-0.310.590.60.720.890.90.880.6-0.370.860.970.72
0.91-0.530.910.90.160.860.880.79-0.53-0.880.80.550.89-0.40.570.510.790.970.90.930.51-0.410.870.850.78
1.0-0.790.820.90.410.990.760.8-0.84-0.70.630.850.78-0.360.710.410.970.80.940.950.41-0.50.90.710.97
0.41-0.560.120.160.410.390.080.21-0.580.02-0.090.560.210.160.53-0.020.440.10.280.4-0.020.370.25-0.050.54
0.98-0.780.760.860.990.390.690.8-0.89-0.630.570.90.69-0.280.670.380.990.760.930.890.38-0.560.90.660.98
0.78-0.50.990.880.760.080.690.71-0.35-0.990.960.420.97-0.280.560.570.650.870.850.850.57-0.340.790.970.65
0.81-0.340.780.790.80.210.80.71-0.63-0.680.670.680.7-0.220.670.80.780.830.880.740.8-0.260.890.730.76
-0.820.8-0.43-0.53-0.84-0.58-0.89-0.35-0.630.25-0.22-0.99-0.360.08-0.64-0.19-0.93-0.42-0.74-0.66-0.190.47-0.72-0.32-0.93
-0.720.41-0.98-0.88-0.70.02-0.63-0.99-0.680.25-0.97-0.31-0.960.3-0.51-0.59-0.57-0.88-0.8-0.82-0.590.33-0.74-0.98-0.57
0.64-0.340.940.80.63-0.090.570.960.67-0.22-0.970.30.88-0.110.460.630.520.830.770.710.63-0.350.730.990.51
0.83-0.80.50.550.850.560.90.420.68-0.99-0.310.30.42-0.060.650.250.940.440.780.670.25-0.480.760.40.94
0.8-0.530.970.890.780.210.690.970.7-0.36-0.960.880.42-0.410.580.520.650.850.840.90.52-0.240.780.90.67
-0.360.17-0.31-0.4-0.360.16-0.28-0.28-0.220.080.3-0.11-0.06-0.41-0.020.04-0.26-0.29-0.28-0.410.040.3-0.27-0.16-0.22
0.71-0.640.590.570.710.530.670.560.67-0.64-0.510.460.650.58-0.020.660.70.570.60.750.66-0.110.50.520.75
0.420.020.60.510.41-0.020.380.570.8-0.19-0.590.630.250.520.040.660.360.660.50.451.00.020.490.650.36
0.97-0.810.720.790.970.440.990.650.78-0.93-0.570.520.940.65-0.260.70.360.690.920.860.36-0.560.880.610.99
0.82-0.350.890.970.80.10.760.870.83-0.42-0.880.830.440.85-0.290.570.660.690.850.860.66-0.280.830.860.68
0.95-0.640.90.90.940.280.930.850.88-0.74-0.80.770.780.84-0.280.60.50.920.850.880.5-0.490.990.840.9
0.96-0.750.880.930.950.40.890.850.74-0.66-0.820.710.670.9-0.410.750.450.860.860.880.45-0.360.810.770.88
0.420.020.60.510.41-0.020.380.570.8-0.19-0.590.630.250.520.040.661.00.360.660.50.450.020.490.650.36
-0.480.5-0.37-0.41-0.50.37-0.56-0.34-0.260.470.33-0.35-0.48-0.240.3-0.110.02-0.56-0.28-0.49-0.360.02-0.46-0.41-0.47
0.91-0.540.860.870.90.250.90.790.89-0.72-0.740.730.760.78-0.270.50.490.880.830.990.810.49-0.460.790.86
0.72-0.40.970.850.71-0.050.660.970.73-0.32-0.980.990.40.9-0.160.520.650.610.860.840.770.65-0.410.790.6
0.97-0.850.720.780.970.540.980.650.76-0.93-0.570.510.940.67-0.220.750.360.990.680.90.880.36-0.470.860.6
Click cells to compare fundamentals

Castle Biosciences Account Relationship Matchups

Castle Biosciences fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets119.7M439.3M462.6M447.3M453.3M307.1M
Short Long Term Debt Total24.5M25.1M8.1M13.3M15.3M14.0M
Other Current Liab7.6M12.1M19.3M27.8M35.1M36.9M
Total Current Liabilities15.3M20.9M24.9M36.1M47.7M24.6M
Total Stockholder Equity85.1M415.7M411.7M399.2M391.3M263.8M
Other Liab55K2.8M19.0M428K492.2K467.6K
Net Tangible Assets85.1M415.7M322.8M272.8M313.7M181.4M
Property Plant And Equipment Net2.1M7.1M16.9M26.5M37.7M39.6M
Net Debt(73.7M)(409.9M)(321.6M)(109.6M)(83.5M)(87.7M)
Retained Earnings(52.2M)(62.5M)(93.8M)(160.9M)(218.4M)(207.5M)
Accounts Payable1.9M2.1M2.5M4.7M10.3M10.8M
Cash98.8M409.9M329.6M122.9M98.8M167.5M
Non Current Assets Total3.1M9.7M108.8M155.0M157.7M165.6M
Non Currrent Assets Other135K1.5M3.0M(25.6M)2.6M2.8M
Other Assets1.0M2.6M3.0M2.2M2.5M2.4M
Cash And Short Term Investments98.8M409.9M329.6M258.6M243.1M211.5M
Net Receivables14.6M12.8M17.3M23.5M38.3M19.4M
Common Stock Shares Outstanding8.7M18.9M25.1M26.1M26.8M19.8M
Liabilities And Stockholders Equity119.7M439.3M462.6M447.3M453.3M307.1M
Non Current Liabilities Total19.3M2.8M25.9M12.1M14.4M13.6M
Inventory1.2M2.2M2.0M4.0M7.9M8.3M
Other Current Assets2.0M9.5M9.6M6.2M6.3M5.5M
Other Stockholder Equity137.3M478.2M505.5M560.4M609.5M360.5M
Total Liab34.6M23.6M50.8M48.2M62.1M43.4M
Net Invested Capital110.2M415.7M411.7M399.2M391.3M261.5M
Property Plant And Equipment Gross2.1M7.1M16.9M26.5M45.9M48.1M
Total Current Assets116.7M429.6M353.7M292.3M295.6M237.7M
Accumulated Other Comprehensive Income(909.4K)(119.7M)0.0(381K)136K142.8K
Net Working Capital101.4M408.7M328.9M256.2M248.0M213.1M
Common Stock1.9K17K25K27K31.1K19.6K
Property Plant Equipment2.1M7.1M16.9M26.5M30.5M32.0M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Castle Biosciences is a strong investment it is important to analyze Castle Biosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Castle Biosciences' future performance. For an informed investment choice regarding Castle Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Castle Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Castle Biosciences. If investors know Castle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Castle Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.93)
Earnings Share
0.21
Revenue Per Share
11.34
Quarterly Revenue Growth
0.395
Return On Assets
(0)
The market value of Castle Biosciences is measured differently than its book value, which is the value of Castle that is recorded on the company's balance sheet. Investors also form their own opinion of Castle Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Castle Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Castle Biosciences' market value can be influenced by many factors that don't directly affect Castle Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Castle Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Castle Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Castle Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.